CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on enhancing cancer treatment through improved radiotherapy techniques using hadron and nanoparticle-enhanced therapies. By understanding nanoscale processes induced by radiation, the project aims to optimize treatment effectiveness while minimizing damage to healthy tissues.
Cancer, the second most common form of death after cardiovascular disease, is a major European health concern.
In 2006, 3.1 million new cases were diagnosed and 1.7 million deaths were attributed to cancer within Europe.
The European Commission has a “European Partnership for Action against Cancer” (IP/09/1380) with the aim of reducing the number of cancer cases by 15% by 2020. A key challenge is to “Develop a more coordinated approach to cancer-related research across Europe”.
Around 50% of pat…
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Denmark, Copenhagen
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
France, CHEVIGNY SAINT SAUVEUR
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
THE QUEEN'S UNIVERSITY OF BELFAST
United Kingdom, Belfast
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
